Cellular Origins and Cell and Gene Therapy Catapult collaborate to demonstrate universal automation of CGT manufacturing

FHS
May 29, 2024
10:49 am

Cellular Origins, a TTP Company focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs), and the Cell and Gene Therapy Catapult (CGT Catapult), an independent innovation and technology organisation specializing in the advancement of the cell and gene therapy industry, today announced a collaboration to demonstrate universal automation of CGT manufacturing.

Hologic expects facility closures in diagnostics division

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Hologic said it expects to

March 28, 2024

Amid GLP-1 mania, health tech’s weight loss startups are trying to prove their services matter

(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.) The rampant success of new prescription GLP-1

February 2, 2024

The Global Cannabis Stock Index Plunges in October

Cannabis stocks, as measured by the Global Cannabis Stock Index, exploded higher in late August on news that the Department of Health and Human Services had

November 1, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.